Cabot reports sight sales increase due to Norit acquisition

Cabot says net earnings for the quarter ended 30 September fell 26%, to $37 million, including a charge primarily for restructuring- and acquisition-related expenses, the company says. Reported adjusted earnings per share of 75 cts/share edged analyst estimates of 73 cts/share, according to Thompson Reuters (New York). Sales were up to $848 million—a 2% increase. The company says the positive sales figures were due to new capacities in China, its acquisition of Norit—a purified solutions maker, and the divestiture of its tantalum business. ...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers